2015
DOI: 10.1517/13543776.2015.1019466
|View full text |Cite
|
Sign up to set email alerts
|

3D-printed biological organs: medical potential and patenting opportunity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
25
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 49 publications
(27 citation statements)
references
References 15 publications
1
25
0
1
Order By: Relevance
“…Different layers of a desired material, mostly in the forms of hydrogel or biodegradable scaffolds, can be printed to form such geometries. Subsequently, biomolecules or cells can be added to defined positions to form various biological structures of interest [50]. As a pioneer of 3D printing, Charles W. Hull introduced the stereolithography method by uniting thin layers of certain materials with ultraviolet light [51].…”
Section: D Bioprintingmentioning
confidence: 99%
“…Different layers of a desired material, mostly in the forms of hydrogel or biodegradable scaffolds, can be printed to form such geometries. Subsequently, biomolecules or cells can be added to defined positions to form various biological structures of interest [50]. As a pioneer of 3D printing, Charles W. Hull introduced the stereolithography method by uniting thin layers of certain materials with ultraviolet light [51].…”
Section: D Bioprintingmentioning
confidence: 99%
“…This potential could be stretched yet further as 3D printing utilises bio-scaffolds to produce actual tissue, or replica tissue, constructed in a process termed bioprinting [25][26][27]. Though little published research has identified the use for this very new technology in simulation training, this opportunity has already been commercially recognised.…”
Section: Accepted M Manuscriptmentioning
confidence: 99%
“…It is hoped that scaffold technology, in combination with 3-dimensional printing, will also enable significant progress in regenerating human organs. 71,72 However, this still seems to be a remote possibility, and, unfortunately, premature clinical trials using normal tissue-derived scaffolds to reconstitute trachea have failed. 73 Other important aspects of stem cell therapeutics are cell delivery and cell dosage.…”
Section: -68mentioning
confidence: 99%